Blue Water Life Science Advisors, LP - Q3 2023 holdings

$106 Million is the total value of Blue Water Life Science Advisors, LP's 7 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .

 Value Shares↓ Weighting
NTRA SellNATERA INC$35,286,543
-17.7%
797,436
-9.5%
33.31%
+15.1%
AKYA  AKOYA BIOSCIENCES INC$21,844,700
-37.1%
4,697,7850.0%20.62%
-12.0%
GH  GUARDANT HEALTH INC$20,038,033
-17.2%
676,0470.0%18.92%
+15.8%
ADPT SellADAPTIVE BIOTECHNOLOGIES COR$12,958,274
-36.3%
2,377,665
-21.5%
12.23%
-10.9%
NSTG BuyNANOSTRING TECHNOLOGIES INC$6,453,253
-41.6%
3,751,891
+37.6%
6.09%
-18.3%
 MAXCYTE INC$5,881,200
-32.0%
1,885,0000.0%5.55%
-4.9%
 SONENDO INC$3,463,093
-45.2%
4,643,4610.0%3.27%
-23.3%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
NATERA INC12Q3 202333.3%
GUARDANT HEALTH INC12Q3 202321.3%
AKOYA BIOSCIENCES INC8Q3 202323.4%
ADAPTIVE BIOTECHNOLOGIES COR8Q3 202317.7%
CAREDX INC7Q2 202219.0%
THERMO FISHER SCIENTIFIC INC5Q4 202116.0%
MAXCYTE INC5Q3 202311.8%
BIO-TECHNE CORP5Q3 20228.8%
SOMALOGIC INC5Q3 20223.8%
CYTEK BIOSCIENCES INC4Q1 202312.5%

View Blue Water Life Science Advisors, LP's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-18
13F-HR2022-02-14
13F-HR2021-11-15

View Blue Water Life Science Advisors, LP's complete filings history.

Compare quarters

Export Blue Water Life Science Advisors, LP's holdings